| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
-Induced Nitric Oxide Production1
* Department of Immunology and Division of Cell Biology, Juntendo University School of Medicine, Tokyo, Japan; and Department of Molecular Immunology, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan
PD-1 is an immunoinhibitory receptor that belongs to the CD28/CTLA-4 family. B7-H1 (PD-L1) and B7-DC (PD-L2), which belong to the B7 family, have been identified as ligands for PD-1. Paradoxically, it has been reported that both B7-H1 and B7-DC costimulate or inhibit T cell proliferation and cytokine production. To determine the role of B7-H1 and B7-DC in T cell-APC interactions, we examined the contribution of B7-H1 and B7-DC to CD4+ T cell activation by B cells, dendritic cells, and macrophages using anti-B7-H1, anti-B7-DC, and anti-PD-1 blocking mAbs. Anti-B7-H1 mAb and its Fab markedly inhibited the proliferation of anti-CD3-stimulated naive CD4+ T cells, but enhanced IL-2 and IFN-
production in the presence of macrophages. The inhibition of T cell proliferation by anti-B7-H1 mAb was abolished by neutralizing anti-IFN- mAb. Coculture of CD4+ T cells and macrophages from IFN--deficient or wild-type mice showed that CD4+ T cell-derived IFN- was mainly responsible for the inhibition of CD4+ T cell proliferation. Anti-B7-H1 mAb induced IFN--mediated production of NO by macrophages, and inducible NO synthase inhibitors abrogated the inhibition of CD4+ T cell proliferation by anti-B7-H1 mAb. These results indicated that the inhibition of T cell proliferation by anti-B7-H1 mAb was due to enhanced IFN- production, which augmented NO production by macrophages, suggesting a critical role for B7-H1 on macrophages in regulating IFN- production by naive CD4+ T cells and, hence, NO production by macrophages.
This article has been cited by other articles:
|
|
 |
|
  K. M. Haas, J. C. Poe, and T. F. Tedder CD21/35 Promotes Protective Immunity to Streptococcus pneumoniae through a Complement-Independent but CD19-Dependent Pathway That Regulates PD-1 Expression J. Immunol., September 15, 2009; 183(6): 3661 - 3671. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Peng, F.-c. Lin, P. H. Verardi, L. A. Jones, and T. D. Yilma Lower Levels of Gamma Interferon Expressed by a Pseudotyped Single-Cycle Simian Immunodeficiency Virus Enhance Immunogenicity in Rats J. Virol., February 15, 2009; 83(4): 1592 - 1601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-S. Chang, J.-Y. Kim, Y.-J. Kim, Y.-S. Kim, J.-M. Lee, M. Azuma, H. Yagita, and C.-Y. Kang Cutting Edge: Programmed Death-1/Programmed Death Ligand 1 Interaction Regulates the Induction and Maintenance of Invariant NKT Cell Anergy J. Immunol., November 15, 2008; 181(10): 6707 - 6710. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-H. Piao, H. Yoshida, W.-C. Yeh, T. Doi, X. Xue, H. Yagita, K. Okumura, and H. Nakano TNF Receptor-Associated Factor 2-Dependent Canonical Pathway Is Crucial for the Development of Peyer's Patches J. Immunol., February 15, 2007; 178(4): 2272 - 2277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hori, M. Wang, M. Miyashita, K. Tanemoto, H. Takahashi, T. Takemori, K. Okumura, H. Yagita, and M. Azuma B7-H1-Induced Apoptosis as a Mechanism of Immune Privilege of Corneal Allografts J. Immunol., November 1, 2006; 177(9): 5928 - 5935. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Freeman, E. J. Wherry, R. Ahmed, and A. H. Sharpe Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade J. Exp. Med., October 2, 2006; 203(10): 2223 - 2227. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
